Data from the clinical trials showed that the vaccine worked better at preventing hospitalization or severe dengue in children 9–16 years old than in younger children. Most of the clinical trials testing the vaccine were done in children 16 years old and younger, because that age group is at highest risk for dengue in areas where dengue occurs frequently.